Get all your news in one place.
100's of premium titles.
One app.
Start reading
Zenger
Zenger
Business
Vandana Singh

OSA Treatment Provider ProSomnus Inc. Delivers Strong Q2 Revenues, With 43% Y/Y Growth

Graphical representation of revenue movement on a laptop screen. ProSomnus Inc delivers strong Q2 revenues, surpassing expectations with 43% Y/Y Growth and a sequential revenue increase of 19%. LUKE CHESSER/UNSPLASH. 

Obstructive Sleep Apnea treatment provider ProSomnus Inc (NASDAQ: OSA) reported Q2 revenues of $6.9 million, up 43% Y/Y and a sequential revenue increase of 19%, slightly beating the consensus of $6.4 million.

Revenue growth and the underlying growth in deliveries of the company’s products reflect the growing clinical adoption of ProSomnus’s precision devices in the U.S. and Europe and the positive impacts of the expanded field sales team during 1H of 2023.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.